Factors associated with effects of COVID-19 vaccine among adults in Malaysia

https://doi.org/10.53730/ijhs.v6nS7.13052

Authors

  • Thin Mon Kyaw Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia, Lecturer, Department of community medicine, University of Cyberjaya, Malaysia Contact No: +60182252711, ORCID ID: 0000-0003-1548-1727
  • Soe Moe Department of Community Medicine, Faculty of Medicine, Manipal University College Malaysia MUCM, Malaysia
  • Myat Thida Win Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia
  • Mya Sanda Khaing Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia
  • Ye Wint Kyaw Faculty of Medicine, SEGi university, Malaysia
  • Vaidehi Chowdhry Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia
  • Subashini AP Sangar Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia
  • Ahmed Al-Fadhli Ahmed Hussein Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia
  • Ragesh Manoharan Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia
  • Zeeshan Abbas Ajaz Faculty of Medicine, University of Cyberjaya, Cyberjaya, Selangor, Malaysia

Keywords:

COVID-19, SARS CoV-2, vaccines, Sinovac, Pfizer, AstraZeneca, adverse effects, Vaccine safety, Malaysia

Abstract

Introduction: Globally, the needs for more focused research to understand the effects of COVID-19 vaccines among the population to verify the previous research and generate more reliable data. Therefore, this cross-sectional study was aimed to identify the factors associated with the effects of COVID-19 vaccination among adults in Malaysia. Methods: Malaysian people aged 18 and up were enrolled in a cross-sectional online survey. For data collection, a Google form was used to design an online questionnaire which was distributed through social media and in person by the author. Results: A total of 446 responses were analyzed. 58% participants received Pfizer BioNTech Covid 19 vaccine followed by Sinovac (21%) and AstraZeneca (16%). The most reported effect was local reaction pain, swelling and redness at the site of injection with 54.3% of participants. It was seen more in Pfizer BioNTech (56.8%) and AstraZeneca (57.1%) recipients in comparison to Sinovac recipients (42.9%), but this difference was not significant (x2=3.453; p-value=0.315). Tiredness/fatigue was the next most reported effect 51.3% by participants. The other more frequently reported effects were body pain (43.3%), muscle pain (41%), fever (41%) and headache (33%) respectively, which are significantly associated with the type of vaccine. 

Downloads

Download data is not yet available.

References

AA, H. 2021. Program Imunisasi Covid-19 Kebangsaan bermula [METROTV] Putrajaya2021

METROTV.

Al-Jighefee, H.T., Najjar, H., Ahmed, M.N., Qush, A., Awwad, S. & Kamareddine, L. 2021. COVID-19 vaccine platforms: Challenges and safety contemplations. Vaccines 9(10): 1196.

Al Khames Aga, Q.A., Alkhaffaf, W.H., Hatem, T.H., Nassir, K.F., Batineh, Y., Dahham, A.T., Shaban, D., Al Khames Aga, L.A., Agha, M.Y. & Traqchi, M. 2021. Safety of COVID‐19 vaccines. Journal of medical virology 93(12): 6588-6594.

AUM Shah, S.S., R Thevadas, NK Noordin. 2020. Malaysian government preventive steps to control SARS-CoV 2 International Journal of environmental research and public health.

Elengoe, A. 2020. COVID-19 outbreak in Malaysia. Osong public health and research perspectives 11(3): 93.

Elnaem, M.H., Mohd Taufek, N.H., Ab Rahman, N.S., Mohd Nazar, N.I., Zin, C.S., Nuffer, W. & Turner, C.J. 2021. COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter? Vaccines 9(10): 1156.

Fisher, D. & Heymann, D. 2020. Q&A: The novel coronavirus outbreak causing COVID-19. BMC medicine 18(1): 1-3.

Health, M.o. 2021. COVIDNOW in Malaysia MOH Malaysia.

JX Li, Y.S., L Wang, XF Zhang, YS Hu. 2016. Expert review of vaccines. Human Vaccines & Immunotherapeutics 17(12).

Malaysia, M.o.h. 2021. Vaccinations in Malaysia: Ministry of health; .

MM Ahamad, S.A., MJ Uddin, M Rashed-Al-Mahfuz. 2021. severe post-vaccination adverse effects. medRxiv.

Mohamad Radhi, N.A.H., Hana Naz. 2021. Phase 4 for NIP activated. ". New Straits Times.

Mohamed, N.A., Solehan, H.M., Mohd Rani, M.D., Ithnin, M. & Che Isahak, C.I. 2021. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS One 16(8): e0256110.

Organization, W.H. 2021. WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations.

Plüddemann, A., Aronson, J.K., Onakpoya, I., Heneghan, C. & Mahtani, K.R. 2018. Redefining rapid reviews: a flexible framework for restricted systematic reviews. BMJ evidence-based medicine 23(6): 201-203.

Ronald N Kostoff, M.B.B., Alan L Porter, Demetrios A Spandidos, Aristidis Tsatsakis. 2020. Long term effects of covid 19 vaccine. International journal of molecular medicine 46(5).

Size, F., Size, F. & WIRE, B. 2020. Pfizer and BioNTech Celebrate Historic First Authorization in the US of Vaccine to Prevent COVID-19.

Sohrabi, C., Alsafi, Z., O'neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C. & Agha, R. 2020. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery 76: 71-76.

SS DeRoo, N.P., LY Fu 2020. covid-19 vaccine's availability Jama.

star, T. 2021a. Covid-19: Refugees in Malaysia to get CanSino vaccine, says Khairy Petling Jaya: . The star journal.

star, T. 2021b. Malaysia to start using AstraZeneca Putrajaya: . The star journal.

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H. & Pei, Y.-Y. 2020. A new coronavirus associated with human respiratory disease in China. Nature 579(7798): 265-269.

Wu, Q., Dudley, M.Z., Chen, X., Bai, X., Dong, K., Zhuang, T., Salmon, D. & Yu, H. 2021. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC medicine 19(1): 1-16.

Xing, K., Tu, X.-Y., Liu, M., Liang, Z.-W., Chen, J.-N., Li, J.-J., Jiang, L.-G., Xing, F.-Q. & Jiang, Y. 2021. Efficacy and safety of COVID-19 vaccines: a systematic review. Chinese Journal of Contemporary Pediatrics 23(3): 221.

Published

28-09-2022

How to Cite

Kyaw, T. M., Moe, S., Win , M. T., Khaing, M. S., Kyaw, Y. W., Chowdhry, V., Sangar, S. A., Hussein, A. A.-F. A., Manoharan, R., & Ajaz, Z. A. (2022). Factors associated with effects of COVID-19 vaccine among adults in Malaysia. International Journal of Health Sciences, 6(S7), 4764–4778. https://doi.org/10.53730/ijhs.v6nS7.13052

Issue

Vol. 6 No. S7 (2022)

Section

Peer Review Articles
Copyright & Licensing

Copyright (c) 2022 International journal of health sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)